Vitamin D, Hypertension, Left Ventricular Hypertrophy, and Diastolic Dysfunction



The extra-skeletal effects of vitamin D have been increasingly recognized in the recent years and its effects on blood pressure and cardiac function are areas of active investigation. This article reviews the current state of knowledge about vitamin D with respect to blood pressure and left ventricular hypertrophy. Potential biological mechanisms implicated in linking vitamin D deficiency with hypertension and cardiac dysfunction are outlined along with data from both observational and randomized controlled trials on this topic.


Vitamin D Hypertension Systolic blood pressure Diastolic blood pressure Left ventricular hypertrophy 


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Teng M, Wolf M, Lowrie E, Ofsthun N, Lazarus JM, Thadhani R. Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med. 2003;349:446–56.PubMedCrossRefGoogle Scholar
  2. 2.
    Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernan MA, Camargo Jr CA, et al. Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol. 2005;16:1115–25.PubMedCrossRefGoogle Scholar
  3. 3.
    Weishaar RE, Kim SN, Saunders DE, Simpson RU. Involvement of vitamin D3 with cardiovascular function. III. Effects on physical and morphological properties. Am J Physiol. 1990;258:E134–42.PubMedGoogle Scholar
  4. 4.
    Weishaar RE, Simpson RU. Vitamin D3 and cardiovascular function in rats. J Clin Invest. 1987;79:1706–12.PubMedCrossRefGoogle Scholar
  5. 5.
    Wu J, Garami M, Cheng T, Gardner DG. 1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes. J Clin Invest. 1996;97:1577–88.PubMedCrossRefGoogle Scholar
  6. 6.
    Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110:229–38.PubMedGoogle Scholar
  7. 7.
    Xiang W, Kong J, Chen S, Cao LP, Qiao G, Zheng W, et al. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab. 2005;288:E125–32.PubMedCrossRefGoogle Scholar
  8. 8.
    Zhou C, Lu F, Cao K, Xu D, Goltzman D, Miao D. Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. Kidney Int. 2008;74:170–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Bodyak N, Ayus JC, Achinger S, Shivalingappa V, Ke Q, Chen YS, et al. Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals. Proc Natl Acad Sci U S A. 2007;104:16810–5.PubMedCrossRefGoogle Scholar
  10. 10.
    Woodhouse PR, Khaw KT, Plummer M, Foley A, Meade TW: Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease. Lancet. 1994; 19;343:435–439Google Scholar
  11. 11.
    Rostand SG. Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension. 1997;30:150–6.PubMedGoogle Scholar
  12. 12.
    Kokot F, Pietrek J, Srokowska S, Wartenberg W, Kuska J, Jedrychowska M, et al. 25-hydroxyvitamin D in patients with essential hypertension. Clin Nephrol. 1981;16:188–92.PubMedGoogle Scholar
  13. 13.
    Sowers MR, Wallace RB, Lemke JH. The association of intakes of vitamin D and calcium with blood pressure among women. Am J Clin Nutr. 1985;42:135–42.PubMedGoogle Scholar
  14. 14.
    Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2007;167:1159–65.PubMedCrossRefGoogle Scholar
  15. 15.
    Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens. 2007;20:713–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Judd SE, Nanes MS, Ziegler TR, Wilson PW, Tangpricha V. Optimal vitamin D status attenuates the age-associated increase in systolic blood pressure in white Americans: results from the third national health and nutrition examination survey. Am J Clin Nutr. 2008;87:136–41.PubMedGoogle Scholar
  17. 17.
    Hypponen E, Boucher BJ, Berry DJ, Power C. 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes. 2008;57:298–305.PubMedCrossRefGoogle Scholar
  18. 18.
    Hintzpeter B, Mensink GB, Thierfelder W, Muller MJ, Scheidt-Nave C. Vitamin D status and health correlates among German adults. Eur J Clin Nutr. 2008;62:1079–89.PubMedCrossRefGoogle Scholar
  19. 19.
    • Burgaz A, Byberg L, Rautiainen S, Orsini N, Hakansson N, Arnlov J, Sundstrom J, Lind L, Melhus H, Michaelsson K, Wolk A: Confirmed hypertension and plasma 25(OH)D concentrations amongst elderly men. J Intern Med 2011; 269:211–218. In this study, investigators confirmed hypertension by both office and 24-hour blood pressure measurements. PubMedCrossRefGoogle Scholar
  20. 20.
    Reis JP. von MD, Kritz-Silverstein D, Wingard DL, Barrett-Connor E: Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care. 2007;30:1549–55.PubMedCrossRefGoogle Scholar
  21. 21.
    Rueda S, Fernandez-Fernandez C, Romero F, de Martinez OJ, Vidal J. Vitamin D, PTH, and the metabolic syndrome in severely obese subjects. Obes Surg. 2008;18:151–4.PubMedCrossRefGoogle Scholar
  22. 22.
    Snijder MB, Lips P, Seidell JC, Visser M, Deeg DJ, Dekker JM, et al. Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women. J Intern Med. 2007;261:558–65.PubMedCrossRefGoogle Scholar
  23. 23.
    •• Wei MY, Giovannucci EL: Vitamin D and multiple health outcomes in the Harvard cohorts. Mol Nutr Food Res 2010; 54:1114–1126. This review summarizes studies of vitamin D and cardiovascular endpoints in Harvard study cohorts PubMedGoogle Scholar
  24. 24.
    Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, Willett WC, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension. 2007;49:1063–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Forman JP, Curhan GC, Taylor EN. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension. 2008;52:828–32.PubMedCrossRefGoogle Scholar
  26. 26.
    Forman JP, Bischoff-Ferrari HA, Willett WC, Stampfer MJ, Curhan GC. Vitamin D intake and risk of incident hypertension: results from three large prospective cohort studies. Hypertension. 2005;46:676–82.PubMedCrossRefGoogle Scholar
  27. 27.
    Wang L, Manson JE, Buring JE, Lee IM, Sesso HD. Dietary intake of dairy products, calcium, and vitamin D and the risk of hypertension in middle-aged and older women. Hypertension. 2008;51:1073–9.PubMedCrossRefGoogle Scholar
  28. 28.
    •• Jorde R, Figenschau Y, Emaus N, Hutchinson M, Grimnes G: Serum 25-hydroxyvitamin D levels are strongly related to systolic blood pressure but do not predict future hypertension. Hypertension. 2010; 55:792–798. This study that confirms an association between vitamin D levels and prevalent hypertension, but investigators did not observe an association between vitamin D level and incident hypertension PubMedCrossRefGoogle Scholar
  29. 29.
    • Griffin FC, Gadegbeku CA, Sowers MR: Vitamin D and Subsequent Systolic Hypertension Among Women. Am J Hypertens. 2010. This prospective study found an association between single-time measure of vitamin D among young adult women with systolic hypertension at 14 years of follow-up Google Scholar
  30. 30.
    • Burgaz A, Orsini N, Larsson SC, Wolk A: Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis. J Hypertens. 2010. This comprehensive systematic review included four prospective studies and 14 cross-sectional studies. It concluded that blood 25-hydroxyvitamin D concentration is inversely associated with hypertension. Google Scholar
  31. 31.
    Zittermann A, Schleithoff SS, Tenderich G, Berthold HK, Korfer R, Stehle P. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol. 2003;41:105–12.PubMedCrossRefGoogle Scholar
  32. 32.
    Zittermann A, Schleithoff SS, Koerfer R. Vitamin D insufficiency in congestive heart failure: why and what to do about it? Heart Fail Rev. 2006;11:25–33.PubMedCrossRefGoogle Scholar
  33. 33.
    Shane E, Mancini D, Aaronson K, Silverberg SJ, Seibel MJ, Addesso V, et al. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med. 1997;103:197–207.PubMedCrossRefGoogle Scholar
  34. 34.
    Pilz S, Marz W, Wellnitz B, Seelhorst U, Fahrleitner-Pammer A, Dimai HP, et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab. 2008;93:3927–35.PubMedCrossRefGoogle Scholar
  35. 35.
    Lind L, Wengle B, Ljunghall S. Blood pressure is lowered by vitamin D (alphacalcidol) during long-term treatment of patients with intermittent hypercalcaemia. A double-blind, placebo-controlled study. Acta Med Scand. 1987;222:423–7.PubMedCrossRefGoogle Scholar
  36. 36.
    Lind L, Lithell H, Skarfors E, Wide L, Ljunghall S. Reduction of blood pressure by treatment with alphacalcidol. A double-blind, placebo-controlled study in subjects with impaired glucose tolerance. Acta Med Scand. 1988;223:211–7.PubMedCrossRefGoogle Scholar
  37. 37.
    Zittermann A, Frisch S, Berthold HK, Gotting C, Kuhn J, Kleesiek K, et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr. 2009;89:1321–7.PubMedCrossRefGoogle Scholar
  38. 38.
    Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD. Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet Med. 2008;25:320–5.PubMedCrossRefGoogle Scholar
  39. 39.
    • Jorde R, Figenschau Y: Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. Eur J Nutr. 2009 Sep;48(6):349–54. This study was designed to study whether supplementation with vitamin D would improve glycemic control in patients with type 2 diabetes. The study did not demonstrate that vitamin D supplementation improves glucose metabolism in subjects with type 2 diabetes but without vitamin D deficiency. PubMedCrossRefGoogle Scholar
  40. 40.
    Scragg R, Khaw KT, Murphy S. Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults. Eur J Clin Nutr. 1995;49:640–6.PubMedGoogle Scholar
  41. 41.
    Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2006;83:754–9.PubMedGoogle Scholar
  42. 42.
    Nagpal J, Pande JN, Bhartia A. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med. 2009;26:19–27.PubMedCrossRefGoogle Scholar
  43. 43.
    Pfeifer M, Begerow B, Minne HW, Nachtigall D, Hansen C. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab. 2001;86:1633–7.PubMedCrossRefGoogle Scholar
  44. 44.
    Major GC, Alarie F, Dore J, Phouttama S, Tremblay A. Supplementation with calcium + vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations. Am J Clin Nutr. 2007;85:54–9.PubMedGoogle Scholar
  45. 45.
    • Margolis KL, Ray RM, Van HL, Manson JE, Allison MA, Black HR, Beresford SA, Connelly SA, Curb JD, Grimm RH, Jr., Kotchen TA, Kuller LH, Wassertheil-Smoller S, Thomson CA, Torner JC: Effect of calcium and vitamin D supplementation on blood pressure: the women’s health initiative randomized trial. Hypertension. 2008; 52:847–855.PubMedCrossRefGoogle Scholar
  46. 46.
    Krause R, Buhring M, Hopfenmuller W, Holick MF, Sharma AM. Ultraviolet B and blood pressure. Lancet. 1998;352:709–10.PubMedCrossRefGoogle Scholar
  47. 47.
    • Judd SE, Raiser SN, Kumari M, Tangpricha V: 1,25-dihydroxyvitamin D3 reduces systolic blood pressure in hypertensive adults: a pilot feasibility study. J Steroid Biochem Mol Biol. 2010; 121:445–447. This pilot study suggests that active vitamin D therapy is as effective as short-term intervention for improving hypertension PubMedCrossRefGoogle Scholar
  48. 48.
    Myrup B, Jensen GF, McNair P. Cardiovascular risk factors during estrogen-norethindrone and cholecalciferol treatment. Arch Intern Med. 1992;152:2265–8.PubMedCrossRefGoogle Scholar
  49. 49.
    Pan WH, Wang CY, Li LA, Kao LS, Yeh SH. No significant effect of calcium and vitamin D supplementation on blood pressure and calcium metabolism in elderly Chinese. Chin J Physiol. 1993;36:85–94.PubMedGoogle Scholar
  50. 50.
    Witham MD, Nadir MA, Struthers AD. Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J Hypertens. 2009;27:1948–54.PubMedCrossRefGoogle Scholar
  51. 51.
    •• Pittas AG, Chung M, Trikalinos T, Mitri J, Brendel M, Patel K, Lichtenstein AH, Lau J, Balk EM: Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med. 2010; 152:307–314. This important meta-analysis concluded that the benefit of vitamin D supplementation on cardiometabolic outcomes is uncertain so far and emphasizes the need for future trials on this topic PubMedGoogle Scholar
  52. 52.
    de Zeeuw D, Agarwal R, Amdahl M, Audhya P, Coyne D, Garimella T, et al. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet. 2010;376:1543–51.PubMedCrossRefGoogle Scholar
  53. 53.
    Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ. 2003;326:469.PubMedCrossRefGoogle Scholar
  54. 54.
    Prince RL, Austin N, Devine A, Dick IM, Bruce D, Zhu K. Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women. Arch Intern Med. 2008;168:103–8.PubMedCrossRefGoogle Scholar
  55. 55.
    Hsia J, Heiss G, Ren H, Allison M, Dolan NC, Greenland P, Heckbert SR, Johnson KC, Manson JE, Sidney S, Trevisan M: Calcium/vitamin D supplementation and cardiovascular events. Circulation. 2007,%20;115:846–854.Google Scholar
  56. 56.
    Park CW, Oh YS, Shin YS, Kim CM, Kim YS, Kim SY, et al. Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis. 1999;33:73–81.PubMedCrossRefGoogle Scholar
  57. 57.
    Kim HW, Park CW, Shin YS, Kim YS, Shin SJ, Kim YS, et al. Calcitriol regresses cardiac hypertrophy and QT dispersion in secondary hyperparathyroidism on hemodialysis. Nephron Clin Pract. 2006;102:c21–9.PubMedCrossRefGoogle Scholar
  58. 58.
    •• Thadhani R, Appelbaum E, Chang Y, Pritchett Y, Bhan I, Agarwal R, Zoccali C, Wanner C, Lloyd-Jones D, Cannata J, Thompson T, Audhya P, Andress D, Zhang W, Ye J, Packham D, Singh B, Zehnder D, Manning WJ, Pachika A, Solomon SD: Vitamin D receptor activation and left ventricular hypertrophy in advanced kidney disease. Am J Nephrol. 2011; 33:139–149. This international, multicenter, randomized controlled trial aims to investigate the effects of oral paricalcitol capsules on changes in cardiac structure and function in subjects with stage 3 or 4 chronic kidney disease who have left ventricular hypertrophy.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Division of NephrologyMassachusetts General HospitalBostonUSA

Personalised recommendations